findmyKOL
Clinical trialNCT01325311CompletedPhase 2Interventional

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

SponsorNational Cancer Institute (NCI)Enrollment15Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This randomized phase II trial studies cholecalciferol and genistein compared to placebo in treating patients with early stage prostate cancer. Cholecalciferol and genistein may slow the growth of cancer cells and may be an effective treatment for prostate cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, United States

  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts, United States

  • Minneapolis Veterans Medical Center

    Minneapolis, Minnesota, United States

  • University of Minnesota Medical Center-Fairview

    Minneapolis, Minnesota, United States

  • University of Rochester

    Rochester, New York, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina, United States

  • Urology San Antonio Research Pa

    San Antonio, Texas, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CholecalciferolGenistein
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
31 Jul 2014
Completion
31 Jul 2014
Last update posted
3 Aug 2016
Registered enrollment
15
Registry id
NCT01325311
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.